MLKL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MLKL monoclonal antibodies for research focused on understanding cell death and inflammation mechanisms. MLKL monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Mixed lineage kinase domain-like protein (MLKL) plays a crucial role in necroptosis, a form of programmed cell death that is distinct from apoptosis. By mediating the cellular response to stress and inflammation, MLKL is essential for maintaining tissue homeostasis and regulating immune responses. Understanding MLKL function is vital for elucidating its involvement in various diseases, including neurodegenerative disorders and cancer. Researchers studying MLKL can explore its role in cell signaling pathways and inflammatory responses. MLKL research continues to reveal new insights into disease mechanisms and potential therapeutic targets. Current investigations focus on how MLKL influences cell death decisions and inflammatory signaling cascades. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of MLKL's role in health and disease.